Table 4.
Clinical characteristics of the patients according to LCR after PSM.
| Characteristics | All patients | LCR | p-Value | |
|---|---|---|---|---|
| Low LCR | High LCR | |||
| N = 114 | N = 57 | N = 57 | ||
| Age, years | 1.00 | |||
| ≤65 | 38 (33.3) | 19 (33.3) | 19 (33.3) | |
| >65 | 76 (66.7) | 38 (66.7) | 38 (66.7) | |
| Sex | 0.568 | |||
| Male | 100 (87.7) | 51 (89.5) | 49 (86.0) | |
| Female | 14 (12.3) | 6 (10.5) | 8 (14.0) | |
| BMI, kg/m2 | 0.677 | |||
| ≤24 | 82 (71.9) | 42 (73.7) | 40 (70.2) | |
| >24 | 32 (28.1) | 15 (26.3) | 17 (29.8) | |
| CCI | 1.00 | |||
| ≤2 | 62 (54.4) | 31 (54.4) | 31 (54.4) | |
| >2 | 52 (45.6) | 26 (45.6) | 26 (45.6) | |
| T stage | 0.954 | |||
| T1 | 42 (36.8) | 20 (35.1) | 22 (38.6) | |
| T2 | 23 (20.2) | 12 (21.1) | 11 (19.3) | |
| T3 | 28 (24.6) | 15 (26.3) | 13 (22.8) | |
| T4 | 21 (18.4) | 10 (17.5) | 11 (19.3) | |
| N stage | 0.826 | |||
| N0 | 87 (76.3) | 44 (77.2) | 43 (75.4) | |
| N+ | 27 (23.7) | 13 (22.8) | 14 (24.6) | |
| M stage | 0.647 | |||
| M0 | 109 (95.6) | 54 (94.7) | 55 (96.5) | |
| M1 | 5 (4.4) | 3 (5.3) | 2 (3.5) | |
| Grade | 0.154 | |||
| Low grade | 2 (1.8) | 2 (3.5) | 0 (0.0) | |
| High grade | 112 (98.2) | 55 (96.5) | 57 (110.0) | |
PSM, propensity score matching; LCR, lymphocyte–C-reactive protein ratio; CCI, comprehensive complication index; BMI, body mass index.